EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Targeted Therapy for the Treatment of Cervical Cancer

Dean E Watkins iD, Daniel J Craig iD, Shahnaz D Vellani iD, Ahmad Hegazi, Kaylee J Fredrickson, Adam Walter, Laura Stanbery, John Nemunaitis

Journal of Clinical Medicine · 15.09.2023 · 12 (18) · 5992

DOI: 10.3390/jcm12185992 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.09.2023. Verfasst von Dean E Watkins und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of Toledo Medical Center, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USA. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer is an international public health crisis, affecting several hundred thousand women annually. While not universally protective due to other risk factors, many such cases are preventable with vaccination against high-risk serotypes of the human papilloma virus (HPV 6, 11, 16, 18, 31, 33, 45, 53, 58). Advanced-stage and recurrent cervical cancers are typically lethal and have been the focus in recent years of the integration of immune checkpoint inhibitors (CPIs) to improve survival. We have consolidated information regarding the role of the immune system in both disease progression and disease clearance with the aid of targeted therapies and immunotherapeutic agents. Additionally, we have characterized the treatment modalities currently indicated as the standard of care—such as bevacizumab and the immune CPIs—and those recently approved or in development, including Tivdak, Vigil, and chimeric antigen receptor (CAR) T-cells.

Schlagwörter

Stichwörter der Autor:innen

HPVcervical cancercheckpoint inhibitorimmunotherapy

Autor:innen und Institutionen

  • University of Toledo Medical Center, College of Medicine and Life Sciences, University of Toledo, Toledo, OH 43614, USA.
  • ProMedica Toledo Hospital, Toledo, OH 43606, USA.
  • Gradalis, Inc., Dallas, TX 75006, USA.

ORCID-Profile: Dean E Watkins, Daniel J Craig, Shahnaz D Vellani

Zitieren

APA

Watkins, D. E., Craig, D. J., Vellani, S. D., Hegazi, A., Fredrickson, K. J., Walter, A., Stanbery, L., & Nemunaitis, J. (2023). Advances in Targeted Therapy for the Treatment of Cervical Cancer. Journal of Clinical Medicine, 12(18), 5992. https://doi.org/10.3390/jcm12185992

Vancouver

Watkins DE, Craig DJ, Vellani SD, Hegazi A, Fredrickson KJ, Walter A, et al. Advances in Targeted Therapy for the Treatment of Cervical Cancer. Journal of Clinical Medicine. 2023;12(18):5992. doi:10.3390/jcm12185992

BibTeX
@article{Watkins2023,
  author = {Watkins, Dean E and Craig, Daniel J and Vellani, Shahnaz D and Hegazi, Ahmad and Fredrickson, Kaylee J and Walter, Adam and Stanbery, Laura and Nemunaitis, John},
  title = {Advances in Targeted Therapy for the Treatment of Cervical Cancer},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {18},
  pages = {5992},
  doi = {10.3390/jcm12185992}
}
Kostenlos starten →